research-article

Postmarketing Drug Safety Surveillance Using Publicly Available Health-Consumer-Contributed Content in Social Media

Authors:

Christopher C. Yang,

Ling JiangAuthors Info & Claims

ACM Transactions on Management Information Systems (TMIS), Volume 5, Issue 1

Article No.: 2, Pages 1 - 21

https://doi.org/10.1145/2576233

Published: 01 April 2014 Publication History

Abstract

Postmarketing drug safety surveillance is important because many potential adverse drug reactions cannot be identified in the premarketing review process. It is reported that about 5% of hospital admissions are attributed to adverse drug reactions and many deaths are eventually caused, which is a serious concern in public health. Currently, drug safety detection relies heavily on voluntarily reporting system, electronic health records, or relevant databases. There is often a time delay before the reports are filed and only a small portion of adverse drug reactions experienced by health consumers are reported. Given the popularity of social media, many health social media sites are now available for health consumers to discuss any health-related issues, including adverse drug reactions they encounter. There is a large volume of health-consumer-contributed content available, but little effort has been made to harness this information for postmarketing drug safety surveillance to supplement the traditional approach. In this work, we propose the association rule mining approach to identify the association between a drug and an adverse drug reaction. We use the alerts posted by Food and Drug Administration as the gold standard to evaluate the effectiveness of our approach. The result shows that the performance of harnessing health-related social media content to detect adverse drug reaction is good and promising.

References

[1]

AdverseEvents. About us. http://www.adverseevents.com/about.php.

[2]

Alan, M. H., Stephanie, J. R., Ronald, K. P., Donald, J. O. H., and Kevin, H. 2007. Using data mining to predict safety actions from FDA adverse event reporting system data. Drug Inf. J. 41, 5, 633.

[3]

Benton, A., Ungar, L., Hill, S., Hennessy, S., Mao, J., Chung, A., and Holmes, J. H. 2011. Identifying potential adverse effects using the web: A new approach to medical hypothesis generation. J. Biomed. Inf. 44, 6, 989.

Digital Library

[4]

Benton, A., Holmes, J., Hill, S., Chung, A., and Ungar, L. 2012. Medpie: An information extraction package for medical message board posts. Bioinf. 28, 5, 743--744.

Digital Library

[5]

Biriell, C. and Edwards, I. R. 1997. Reasons for reporting adverse drug reactions--Some thoughts based on an international review. Pharmacoepidemiol. Drug Safety, 6, 1, 21--26.

[6]

Chee, B. W., Berlin, R., and Schatz, B. 2011. Predicting adverse drug events from personal health messages. In Proceedings of the Annual AMIA Symposium. 217--226.

[7]

DuMouchel, W. 1999. Bayesian data mining in large frequency tables, with an application to the FDA spontaneous reporting system. Amer. Statist. 53, 3, 177--190.

[8]

Edwards, I. R. and Aronson, J. K. 2000. Adverse drug reactions: Definitions, diagnosis, and management. Lancet 356, 9237, 1255--1259.

[9]

Evans, S. J. W., Waller, P. C., and Davis, S. 2001. Use of proportional reporting ratios (PRRS) for signal generation from spontaneous adverse drug reaction reports. Pharmacoepidemiol. Drug Safety, 10, 6, 483--486.

[10]

Fox, S. 2013. Pew internet: Health. http://www.pewinternet.org/Commentary/2011/November/Pew-Internet-Health.aspx.

[11]

Hakobyan, L., Haaijer-Ruskamp, F. M., De Zeeuw, D., Dobre, D., and Denig, P. 2011. A review of methods used in assessing non-serious adverse drug events in observational studies among type 2 diabetes mellitus patients. Health Qual. Life Outcomes 9, 1, 83--83.

[12]

Han, J., Kamber, M., and Pei, J. 2006. Data Mining: Concepts and Techniques. Elsevier.

Digital Library

[13]

Hauben, M. 2004. Early postmarketing drug safety surveillance: Data mining points to consider. Ann. Pharmacotherapy 38, 10, 1625--1630.

[14]

Hazell, L. and Shakir, S. A. W. 2006. Under-reporting of adverse drug reactions: A systematic review. Drug Safety 29, 5, 385--396.

[15]

Hofer-Dueckelmann, C., Prinz, E., Beindl, W., Szymanski, J., Fellhofer, G., Pichler, M., and Schuler, J. 2011. Adverse drug reactions (ADRS) associated with hospital admissions - Elderly female patients are at highest risk. Int. J. Clinical Pharmacol. Therapeutics 49, 10, 577--586.

[16]

Ji, Y., Massanari, R. M., Ager, J., Yen, J., Miller, R. E., and Ying, H. 2007. A fuzzy logic-based computational recognition-primed decision model. Inf. Sci. 177, 20, 4338--4353.

Digital Library

[17]

Ji, Y., Ying, H., Dews, P., Farber, M. S., Mansour, A., Tran, J., and Massanari, R. M. 2010. A fuzzy recognition-primed decision model-based causal association mining algorithm for detecting adverse drug reactions in postmarketing surveillance. In Proceedings of the IEEE International Conference on Fuzzy Systems (FUZZ’10). 1--8.

[18]

Ji, Y., Hao, Y., Dews, P., Mansour, A., Tran, J., Miller, R. E., and Massanari, R. M. 2011a. A Potential causal association mining algorithm for screening adverse drug reactions in postmarketing surveillance. IEEE Trans. Inf. Technol. Biomed. 15, 3, 428--437.

Digital Library

[19]

Ji, Y., Ying, H., Dews, P., Mansour, A., Tran, J., Miller, R. E., and Massanari, R. M. 2011b. A potential causal association mining algorithm for screening adverse drug reactions in postmarketing surveillance. IEEE Trans. Inf. Technol. Biomed. 15, 3, 428--437.

Digital Library

[20]

Jin, H., Chen, J., He, H., Williams, G. J., Kelman, C., and O’Keefe, C. M. 2008. Mining unexpected temporal associations: Applications in detecting adverse drug reactions. IEEE Trans. Inf. Technol. Biomed. 12, 4, 488--500.

Digital Library

[21]

Kohn, L. T., Corrigan, J., and Donaldson, M. S., Eds. 2000. To Err is Human: Building a Safer Health System. National Academy Press, Washington, D.C.

[22]

Kongkaew, C., Noyce, P. R., and Ashcroft, D. M. 2008. Hospital admissions associated with adverse drug reactions: A systematic review of prospective observational studies. Ann. Pharmacotherapy, 42, 7, 1017--1025.

[23]

Kubota, K., Koide, D., and Hirai, T. 2004. Comparison of data mining methodologies using japanese spontaneous reports. Pharmacoepidemiol. Drug Safety, 13, 6, 387--394.

[24]

Lanctot, K. L. and Naranjo, C. A. 1994. Computer-assisted evaluation of adverse events using a bayesian-approach. J. Clinical Pharmacol. 34, 2, 142--147.

[25]

Lazarou, J., Pomeranz, B. H., and Corey, P. N. 1998. Incidence of adverse drug reactions in hospitalized patients: A meta-analysis of prospective studies. J. Amer. Med. Assoc. 279, 15, 1200--1205.

[26]

Leaman, R., Wojtulewicz, L., Sullivan, R., Skariah, A., Yang, J., and Gonzalez, G. 2010. Towards internet-age pharmacovigilance: Extracting adverse drug reactions from user posts to health-related social networks. In Proceedings of the Workshop on Biomedical Natural Language Processing (ACL’10). 117--125.

Digital Library

[27]

Lindquist, M., Edwards, I. R., Bate, A., Fucik, H., Nunes, A. M., and Stahl, M. 1999. From association to alert - A revised approach to international signal analysis. Pharmacoepidemiol. Drug Safety 1, 15--25.

[28]

MedHelp. 1994. Medical information, forums and communities. http://www.medhelp.org/aboutus.htm.

[29]

Nikfarjam, A. and Gonzalez, G. H. 2011. Pattern mining for extraction of mentions of adverse drug reactions from user comments. In Proceedings of the AMIA Annual Symposium. 1019--1026.

[30]

Park, M. Y., Yoon, D., Lee, K., Kang, S. Y., Park, I., Lee, S. H., and Kim, J. H. 2011. A novel algorithm for detection of adverse drug reaction signals using a hospital electronic medical record database. Pharmacoepidemiol. Drug Safety 20, 6, 598--607.

[31]

Pouliot, Y., Chiang, A. P., and Butte, A. J. 2011. Predicting adverse drug reactions using publically available pubchem bioassay data. Clinical Pharmacol. Therapeutics 90, 1, 90--99.

[32]

SideEffective. 2014. SideEffective - The voice of web about medications. http://www.sideeffective.com/about/.

[33]

Szarfman, A., Tonning, J. M., and Doraiswamy, P. M. 2004. Pharmacovigilancein the 21st century: New systematic tools for an old problem. Pharmacotherapy, 24, 1099--1104.

[34]

Tatonetti, N., Denny, J., Murphy, S., Fernald, G., Krishnan, G., Castro, V., and Roden, D. 2011. Detecting drug interactions from adverse-event reports: Interaction between paroxetine and pravastatin increases blood glucose levels. Clinical Pharmacol. Therapeutics, 90, 1, 133--142.

[35]

Treato. 2013. Treato: Patient intelligence based on real-life experiences. http://treato.com/about/.

[36]

van Puijenbroek, E. P., Egberts, A. C. G., Meyboom, R. H. B., and Leufkens, H. G. M. 1999. Signalling possible drug--Drug interactions in a spontaneous reporting system: Delay of withdrawal bleeding during concomitant use of oral contraceptives and itraconazole. Brit. J. Clinical Pharmacol. 47, 689--693.

[37]

Wang, X., Hripcsak, G., Markatou, M., and Friedman, C. 2009. Active computerized pharmacovigilance using natural language processing, statistics, and 22 electronic health records: A feasibility study. J. Amer. Med. Inf. Assoc. 16, 3, 328--337.

[38]

White, R. W., Tatonetti, N. P., Shah, N. H., Altman, R. B., and Horvitz, E. 2013. Web-scale pharmacovigilance: Listening to signals from the crowd. J. Amer. Med. Informatics Assoc. 20, 3, 404--408.

[39]

Wood, A. J. J. 2000. Thrombotic thrombocytopenic purpura and clopidogrel --- A need for new approaches to drug safety. New England J. Med. 342, 24, 1824--1826.

[40]

Wu, Y. T. and Makuch, R. W. 2006. Detecting rare adverse events in postmarketing studies: Sample size considerations. Drug Inf. J. 40, 1, 89--98.

[41]

Yang, C. C., Jiang, L., Yang, H., and Tang, X. 2012. Detecting signals of adverse drug reactions from health consumer contributed content in social media. In Proceedings of the ACM SIGKDD Workshop on Health Informatics.

[42]

Zeng, Q. T. and Tse, T. 2006. Exploring and developing consumer health vocabularies. J. Amer. Med. Inf. Assoc. 13, 1, 24--29.

[43]

Zeng, Q. T., Tse, T., Divita, G., Keselman, A., Crowell, J., and Browne, A. C. 2006. Exploring lexical forms: First-generation consumer health vocabularies. In Proceedings of the AMIA Annual Symposium. 1155--1155.

Cited By

Putalpattu MBhargavi KMayani MSrinivas PSiddiqa AKunkulagunta M(2024)Advancing Predictive Modeling in Healthcare A Data Science Approach Utilizing AI-Driven Algorithms2024 International Conference on Intelligent Computing and Emerging Communication Technologies (ICEC)10.1109/ICEC59683.2024.10837024(1-6)Online publication date: 23-Nov-2024
https://doi.org/10.1109/ICEC59683.2024.10837024
Allen MWightman GZhu ZPoliak ASmith DDredze MAyers J(2024)Pharmacovigilance in the Age of Legalized Cannabis: Using Social Media to Monitor Drug–Drug Interactions Between Immunosuppressants and Cannabis-Derived ProductsDrug Safety10.1007/s40264-024-01481-xOnline publication date: 18-Sep-2024
https://doi.org/10.1007/s40264-024-01481-x
Zia ANandave MKumar A(2024)Current Challenges and Future Perspectives: PharmacovigilancePharmacovigilance Essentials10.1007/978-981-99-8949-2_18(365-380)Online publication date: 4-Apr-2024
https://doi.org/10.1007/978-981-99-8949-2_18
Show More Cited By

Index Terms

Postmarketing Drug Safety Surveillance Using Publicly Available Health-Consumer-Contributed Content in Social Media

Recommendations

Using Health-Consumer-Contributed Data to Detect Adverse Drug Reactions by Association Mining with Temporal Analysis
Regular Papers and Special Section on Intelligent Healthcare Informatics

Since adverse drug reactions (ADRs) represent a significant health problem all over the world, ADR detection has become an important research topic in drug safety surveillance. As many potential ADRs cannot be detected though premarketing review, drug ...
Social media mining for drug safety signal detection
SHB '12: Proceedings of the 2012 international workshop on Smart health and wellbeing

Adverse Drug Reactions (ADRs) represent a serious problem all over the world. They may complicate a patient's medical conditions and increase the morbidity, even mortality. Drug safety currently depends heavily on post-marketing surveillance, because ...
Identifying Unknown Adverse Drug Reaction Signal Pairs in Postmarketing Surveillance Using an Active Multi-agent System Approach
CITWORKSHOPS '08: Proceedings of the 2008 IEEE 8th International Conference on Computer and Information Technology Workshops

Discovering unknown adverse drug reactions (ADRs) in postmarketing surveillance as early as possible is of great importance. The current approach to postmarketing surveillance primarily relies on spontaneous reporting. It is passive and suffers from ...

Comments

Information & Contributors

Information

Published In

cover image ACM Transactions on Management Information Systems

ACM Transactions on Management Information Systems Volume 5, Issue 1

April 2014

106 pages

ISSN:2158-656X

EISSN:2158-6578

DOI:10.1145/2603738

Editor:
Hsinchun Chen
University of Arizona, USA

Issue’s Table of Contents

Copyright © 2014 ACM.

Permission to make digital or hard copies of all or part of this work for personal or classroom use is granted without fee provided that copies are not made or distributed for profit or commercial advantage and that copies bear this notice and the full citation on the first page. Copyrights for components of this work owned by others than ACM must be honored. Abstracting with credit is permitted. To copy otherwise, or republish, to post on servers or to redistribute to lists, requires prior specific permission and/or a fee. Request permissions from [email protected]

Publisher

Association for Computing Machinery

New York, NY, United States

Publication History

Published: 01 April 2014

Accepted: 01 January 2014

Revised: 01 November 2013

Received: 01 December 2012

Published in TMIS Volume 5, Issue 1

Permissions

Request permissions for this article.

Request Permissions

Check for updates

Author Tags

Qualifiers

Research-article
Research
Refereed

Contributors

Other Metrics

View Article Metrics

Bibliometrics & Citations

Bibliometrics

Article Metrics

57
Total Citations
View Citations
739
Total Downloads

Downloads (Last 12 months)27
Downloads (Last 6 weeks)4

Reflects downloads up to 03 Mar 2025

Other Metrics

View Author Metrics

Citations

Cited By

Putalpattu MBhargavi KMayani MSrinivas PSiddiqa AKunkulagunta M(2024)Advancing Predictive Modeling in Healthcare A Data Science Approach Utilizing AI-Driven Algorithms2024 International Conference on Intelligent Computing and Emerging Communication Technologies (ICEC)10.1109/ICEC59683.2024.10837024(1-6)Online publication date: 23-Nov-2024
https://doi.org/10.1109/ICEC59683.2024.10837024
Allen MWightman GZhu ZPoliak ASmith DDredze MAyers J(2024)Pharmacovigilance in the Age of Legalized Cannabis: Using Social Media to Monitor Drug–Drug Interactions Between Immunosuppressants and Cannabis-Derived ProductsDrug Safety10.1007/s40264-024-01481-xOnline publication date: 18-Sep-2024
https://doi.org/10.1007/s40264-024-01481-x
Zia ANandave MKumar A(2024)Current Challenges and Future Perspectives: PharmacovigilancePharmacovigilance Essentials10.1007/978-981-99-8949-2_18(365-380)Online publication date: 4-Apr-2024
https://doi.org/10.1007/978-981-99-8949-2_18
Al-Adwan AYaseen H(2023)Solving the product uncertainty hurdle in social commerce: The mediating role of seller uncertaintyInternational Journal of Information Management Data Insights10.1016/j.jjimei.2023.1001693:1(100169)Online publication date: Apr-2023
https://doi.org/10.1016/j.jjimei.2023.100169
Gao YDuan WRui H(2022)Does Social Media Accelerate Product Recalls? Evidence from the Pharmaceutical IndustryInformation Systems Research10.1287/isre.2021.109233:3(954-977)Online publication date: 1-Sep-2022
https://dl.acm.org/doi/10.1287/isre.2021.1092
Yahya AAsiri YAlyami I(2022)Social Media Analytics for Pharmacovigilance of Antiepileptic DrugsComputational and Mathematical Methods in Medicine10.1155/2022/89652802022(1-24)Online publication date: 4-Jan-2022
https://doi.org/10.1155/2022/8965280
Yahya AAsiri Y(2022)Automatic Detection of Adverse Drug Reactions from Online Health Forums2022 13th International Conference on Information and Communication Systems (ICICS)10.1109/ICICS55353.2022.9811144(416-421)Online publication date: 21-Jun-2022
https://doi.org/10.1109/ICICS55353.2022.9811144
Xia L(2022)Historical profile will tell? A deep learning-based multi-level embedding framework for adverse drug event detection and extractionDecision Support Systems10.1016/j.dss.2022.113832160:COnline publication date: 1-Sep-2022
https://dl.acm.org/doi/10.1016/j.dss.2022.113832
Yang C(2022)Explainable Artificial Intelligence for Predictive Modeling in HealthcareJournal of Healthcare Informatics Research10.1007/s41666-022-00114-16:2(228-239)Online publication date: 11-Feb-2022
https://doi.org/10.1007/s41666-022-00114-1
Ahuja VA. Alvarez CBirge JSyverson C(2021)Enhancing Regulatory Decision Making for Postmarket Drug SafetyManagement Science10.1287/mnsc.2020.388967:12(7493-7510)Online publication date: 1-Dec-2021
https://dl.acm.org/doi/10.1287/mnsc.2020.3889
Show More Cited By

View Options

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Full Access

Get this Article

View options

PDF

View or Download as a PDF file.

eReader

View online with eReader.

Figures

Tables

Media

View Issue’s Table of Contents